Clinical Pediatrics: Open Access
Open Access

Childhood infections: clinical approaches and management

Rohan Deshmukh^{* *}Correspondence: Rohan Deshmukh, Department of Pediatric Infectious Diseases, Horizon Medical University, Hyderabad, Telangana, India, Email:

Author info »

Description

Childhood infections remain one of the most significant causes of morbidity and mortality worldwide, particularly in low- and middle-income countries where access to timely healthcare, vaccination coverage, and sanitation facilities may be limited. The pediatric population is especially vulnerable to infectious diseases due to their developing immune systems, frequent exposure in school and community environments, and limited prior immunity to many pathogens. Clinical approaches to managing childhood infections require a combination of early recognition, accurate diagnosis, appropriate antimicrobial therapy, supportive care, and preventive strategies to reduce recurrence and transmission. Over time, advances in medical science have significantly improved survival rates, yet infectious diseases continue to pose a major challenge in pediatric healthcare systems [1].

The immune system of children, especially infants and young toddlers, is still in the developmental phase, which makes them more susceptible to bacterial, viral, fungal, and parasitic infections. Neonates are particularly vulnerable because they rely heavily on maternal antibodies transferred through the placenta and breastfeeding. As maternal immunity wanes and the child’s own immune system matures, susceptibility to infections such as respiratory tract infections, gastroenteritis, and skin infections increases. This period requires heightened clinical vigilance, as early symptoms may be nonspecific and progress rapidly if not treated appropriately [2].

Respiratory infections are among the most common childhood illnesses and include conditions such as pneumonia, bronchiolitis, influenza, and upper respiratory tract infections. Pneumonia remains a leading cause of death in children under five years of age globally. Clinical management depends on identifying the causative agent, which may be bacterial, viral, or occasionally fungal. In many cases, empirical antibiotic therapy is initiated based on clinical severity and local resistance patterns. Supportive care, including oxygen therapy, hydration, and fever management, plays a crucial role in recovery. Vaccination against pathogens such as Streptococcus pneumoniae and Haemophilus influenzae type B has significantly reduced the burden of severe respiratory infections in children.

Gastrointestinal infections are another major category affecting pediatric populations. Viral agents such as rotavirus and norovirus are common causes of acute diarrhea, while bacterial pathogens like Escherichia coli, Salmonella, and Shigella can lead to more severe disease. Dehydration remains the most dangerous complication of diarrheal illnesses in children. Clinical management primarily focuses on prompt rehydration using oral rehydration solutions or intravenous fluids in severe cases. Antibiotics are reserved for specific bacterial infections, as unnecessary use can contribute to antimicrobial resistance. Nutritional support is also important during and after infection to prevent malnutrition and promote recovery of gut function [3].

Skin and soft tissue infections are frequently encountered in pediatric clinical practice and include conditions such as impetigo, cellulitis, abscesses, and fungal infections. These infections often arise due to minor skin injuries, poor hygiene, or close contact in school environments. Management typically involves topical or systemic antibiotics depending on severity, along with proper wound care and hygiene education. Fungal infections such as tinea capitis and candidiasis may require antifungal treatment. Preventive measures, including maintaining cleanliness and avoiding sharing personal items, are essential to reduce transmission [4].

Urinary tract infections are also common in children, particularly in infants and young girls. Symptoms may include fever, irritability, abdominal pain, or changes in urinary patterns. Diagnosis is confirmed through urine analysis and culture. Early treatment with appropriate antibiotics is important to prevent complications such as renal scarring or recurrent infections. In recurrent cases, further evaluation may be required to identify underlying anatomical abnormalities or vesicoureteral reflux [5].

Viral infections such as measles, mumps, rubella, and varicella remain important concerns despite widespread vaccination efforts. Measles, in particular, can lead to severe complications including pneumonia, encephalitis, and immune suppression. Management of viral infections is generally supportive, focusing on symptom relief, hydration, and prevention of secondary bacterial infections. Vaccination programs have dramatically reduced the incidence of these diseases, highlighting the importance of immunization as a cornerstone of pediatric infection control [6].

Emerging and re-emerging infectious diseases continue to challenge pediatric healthcare systems. Viral outbreaks such as influenza pandemics and coronavirus infections have demonstrated the vulnerability of children to novel pathogens. Clinical management in such cases requires rapid identification, isolation protocols, supportive care, and in some cases, antiviral medications. The coronavirus pandemic particularly emphasized the importance of infection control measures, telemedicine, and global collaboration in managing pediatric infectious diseases [7].

Antimicrobial resistance is a growing concern in the management of childhood infections. The overuse and misuse of antibiotics have led to the emergence of resistant bacterial strains, making infections harder to treat. Clinicians must adopt rational prescribing practices based on evidence, culture sensitivity results, and established guidelines. Education of caregivers regarding appropriate antibiotic use is also essential to reduce unnecessary demand and self-medication [8].

Preventive strategies play a critical role in reducing the burden of childhood infections. Immunization remains the most effective public health intervention, protecting children against a wide range of infectious diseases. Improvements in sanitation, clean water access, and hygiene practices significantly reduce transmission of gastrointestinal and parasitic infections. Breastfeeding provides passive immunity and strengthens infant defenses against infections. School health programs and community awareness initiatives further contribute to early detection and prevention [9].

Clinical management of childhood infections also requires a multidisciplinary approach involving pediatricians, nurses, microbiologists, and public health professionals. Early diagnosis, often supported by laboratory investigations such as blood tests, cultures, imaging, and molecular diagnostics, ensures timely and targeted treatment. In severe cases, hospitalization and intensive care support may be required to manage complications such as sepsis or respiratory failure [10].

Conclusion

Childhood infections remain a major global health concern, but advances in clinical medicine, vaccination, diagnostics, and supportive care have significantly improved outcomes. Effective management requires early recognition, appropriate treatment, and strong preventive strategies. Addressing challenges such as antimicrobial resistance, healthcare access disparities, and emerging infectious diseases is essential for further reducing the burden of infections in children.

References

1. Kazerooni AF, Familiar AM, Aboian M, Brüningk SC, Vossough A, Linguraru MG, et al. Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: Challenges, opportunities, and recommendations for clinical translation. Lancet Oncol. 2025; 26(11):e607-618.

   [Crossref] [Google Scholar] [Pubmed]

2. Berger RM, Ivy DD, Borissoff JI, Cerovic S, Csonka D, Remeňová T, et al. Macitentan vs Standard of Care in Pediatric Pulmonary Arterial Hypertension (TOMORROW): A Randomized Clinical Trial. J Pediatr. 2026;115057.

   [Crossref] [Google Scholar] [Pubmed]

3. Macho V, e Silva D, Silva CC, Manso MC, Rodrigues R. Nutritional surveillance and diet adherence in pediatric celiac disease: A multidisciplinary case-control study within a clinical nutrition model. Clin Nutr ESPEN. 2026;103298.

   [Crossref] [Google Scholar] [Pubmed]

4. Savaş EH, Coşkun AB, Elmaoğlu E, Semerci R, Şahiner NC. Investigating the effects of augmented reality-based interventions on pediatric patient outcomes in the clinical setting: A systematic review. J Pediatr Nurs. 2025;85:39-47.

   [Crossref] [Google Scholar] [Pubmed]

5. Gültekin TT, Kutsal AG, Yörüsün G, Selmanoğlu A, Çelebier K, Emeksiz ZŞ, et al. Evaluation of the awareness of pediatric residents of anaphylaxis diagnosis through clinical scenarios. World Allergy Organ J. 2025;18(7):101076.

   [Crossref] [Google Scholar] [Pubmed]

6. Hu H, Chen H, Yu Z, Zhou Y, Li L, Zhai X, el at. Clinical outcome and health-related quality of life in Pediatric intracranial aneurysm: A single-center experience. World Neurosurg. 2025;124500.

   [Crossref] [Google Scholar] [Pubmed]

7. Glasser NJ, Shirkhodaie C, Newman ZC, Wang J, Zhu M, Mitchell JW, et al. Evaluating clinical decision supports to improve adolescent depression screening and management in pediatric primary care. Acad Pediatr. 2025; 25(6):102839.

   [Crossref] [Google Scholar] [Pubmed]

8. Kline S, Reed AM, McCarty L, Brown D, Fuste A, Kirstein K, et al. Two steps forward, one step back: The complexity of accurately defining and measuring clinical activity in academic pediatrics. The J Pediatr. 2023; 259.

   [Crossref] [Google Scholar] [Pubmed]

9. McGrady ME, Ignjatovic V, Jones S, Bruce A, Goldenberg NA, Rizzi M, et al. Evaluation, analysis, and reporting of medication adherence for clinical trials of anticoagulants in children: Guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. J Thromb Haemost. 2024;22(7):2081-2092.

   [Crossref] [Google Scholar] [Pubmed]

10. Gravel J, Grandjean-Blanchet C, Loghin AD, Noyon B, Ostrow O, Vallières É, et al. Derivation and validation of a clinical rule to detect bacteremia versus contaminants in positive pediatric blood cultures: a retrospective cohort study. Ann Emerg Med. 2025.

    [Crossref] [Google Scholar] [Pubmed]